Keynote Speakers

Joseph KOST
Professor D.Sc.
Ben-Gurion University of the Negev (BGU)

Joseph Kost D.Sc. is University Distinguished Professor, he holds The Abraham and Bessie Zacks Chair in Biomedical Engineering, and was the Dean of the Faculty of Engineering Sciences at Ben-Gurion University of the Negev (BGU). Kost completed his undergraduate and graduate degrees in Chemical Engineering at the Technion, Israel Institute of Technology, before earning a doctorate in Biomedical Engineering at the same institution. Later he also earned an M.B.A. from BGU’s Department of Management. He is a Fellow of the American Institute for Medical and Biological Engineering, an International Member of the United States National Academy of Engineering (NAE), an Honorary Fellow of the Israel Institute of Chemical Engineers, a Member of the Controlled Release Society College of Fellows, Doctor Honoris Causa, Transilvania University of Brasov, Romania and a Member of the Israel Academy of Sciences and Humanities. Co-author of 154 publications 64 patents and patents publications, with 13240 citations and h-index of 58. His research interests are in the field of biomedical engineering, biomaterials science, controlled drug delivery, gene therapy and ultrasound. 

*
*     *
NANOPARTICLES AND ULTRASOUND FOR TARGETED THERAPIES

The targeted drug delivery and gene therapy through natural biodegradable nanoparticles is an area of major interest in the field of nanotechnology and pharmaceuticals. The nanoparticles used consist of different biodegradable materials such as natural or synthetic polymers, lipids, or metals. The specific cell targeting is of utmost importance in gene therapy where the main goal is the development of efficient, non-toxic gene carriers that can condense and deliver foreign genetic materials into specific cell types. Viral and non-viral carriers have been developed and some already have been approved for cancer and blindness. Still in many studies, the transfection efficiency is too low due to biological barriers in the transfection process. Physical approaches to increase efficacy and targeting to specific tissues have been also studies. In the presentation the drug delivery aspects of nanomedicine, the molecular mechanisms underlying the interactions of nanoparticles with cell-surface receptors, biological responses and ultrasound as a targeting tool and its effect on extra and intra cellular transport would be discussed. 

 

Firstname SURNAME
PhD
Professor 
Affiliation 1 
Affiliation 1 

Short CV of the keynote speaker 

*
*     *
TITLE OF THE PRESENTATION 

Abstract of the presented research. 

 

Firstname SURNAME
PhD
Professor 
Affiliation 1 
Affiliation 1 

Short CV of the keynote speaker 

*
*     *
TITLE OF THE PRESENTATION 

Abstract of the presented research.